Details for Patent: 10,195,151

Which drugs does patent 10,195,151 protect, and when does it expire?

Patent 10,195,151 protects SUNOSI and is included in one NDA.

This patent has twenty-one patent family members in eighteen countries.

Summary for Patent: 10,195,151

Patent landscape, scope, and claims:

Title:	Formulations of (R)-2-amino-3-phenylpropyl carbamate
Abstract:	The present invention relates to immediate release formulations of (R)-2-amino-3-phenylpropyl carbamate and methods of using the same to treat disorders.
Inventor(s):	Allphin; Clark Patrick (Seattle, WA), Walsh; Edwin Gerard (Dublin, IE)
Assignee:	Jazz Pharmaceuticals International III Limited (Hamilton, BM)
Application Number:	15/695,913
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,195,151
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Delivery; Dosage form;

Drugs Protected by US Patent 10,195,151

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Axsome Malta	SUNOSI	solriamfetol hydrochloride	TABLET;ORAL	211230-001	Jun 17, 2019		RX	Yes	No	10,195,151		Y
Axsome Malta	SUNOSI	solriamfetol hydrochloride	TABLET;ORAL	211230-002	Jun 17, 2019		RX	Yes	Yes	10,195,151		Y

International Family Members for US Patent 10,195,151

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2017324855
Canada	3036068
Chile	2019000571
China	109906078
Denmark	3509581